Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition

References

• Kjems J, Gothelf AB, Håkansson K, et al. Elective nodal irradiation and patterns of failure in head and neck cancer after primary radiation therapy. Int J Radiat Oncol Biol Phys. 2016;94(4):775–782. doi: 10.1016/j.ijrobp.2015.12.380.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Tiwari R, Nauta JJ, et al. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73(1):187–190. doi: 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J.
   PubMed Web of Science ®Google Scholar
• Lala M, Chirovsky D, Cheng JD, et al. Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review. Oral Oncol. 2018;84:108–120. doi: 10.1016/j.oraloncology.2018.07.005.
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol. 2010;21 Suppl 7:vii252–61. doi: 10.1093/annonc/mdq453.
   PubMedGoogle Scholar
• Colevas AD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol. 2006;24(17):2644–2652. doi: 10.1200/JCO.2005.05.3348.
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Chakrabarti PR, Desai SM, et al. Spectrum of second primary malignant neoplasms in Central India: case series from a tertiary care Centre. Niger Postgrad Med J. 2015;22(4):233–236. doi: 10.4103/1117-1936.173975.
   PubMedGoogle Scholar
• Morris LG, Sikora AG, Hayes RB, et al. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control. 2011;22(5):671–679. doi: 10.1007/s10552-011-9739-2.
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ, Tabor MP, Leemans CR, et al. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck. 2002;24(2):198–206. doi: 10.1002/hed.10042.
   PubMed Web of Science ®Google Scholar
• Jovanovic A, van der Tol IG, Kostense PJ, et al. Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma. Eur J Cancer B Oral Oncol. 1994;30b(4):225–229. doi: 10.1016/0964-1955(94)90001-9.
   PubMed Web of Science ®Google Scholar
• Rohde M, Rosenberg T, Pareek M, et al. Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense-Birmingham definition. Eur Arch Otorhinolaryngol. 2020;277(6):1593–1599. doi: 10.1007/s00405-020-05953-5.
   PubMed Web of Science ®Google Scholar
• Lindegaard AM, von Buchwald C, Rasmussen JH, et al. Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer. Head Neck. 2020;42(11):3161–3170. doi: 10.1002/hed.26361.
   PubMed Web of Science ®Google Scholar
• Mehanna H, Kong A, Ahmed SK. Recurrent head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016;130(S2):S181–s190. doi: 10.1017/S002221511600061X.
   PubMedGoogle Scholar
• Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92. doi: 10.1038/s41572-020-00224-3.
   PubMed Web of Science ®Google Scholar
• Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323(12):795–801. doi: 10.1056/NEJM199009203231205.
   PubMed Web of Science ®Google Scholar
• Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571–578. doi: 10.1016/s0360-3016(01)01690-x.
   PubMed Web of Science ®Google Scholar
• Zukauskaite R, Hansen CR, Grau C, et al. Local recurrences after curative IMRT for HNSCC: effect of different GTV to high-dose CTV margins. Radiother Oncol. 2018;126(1):48–55. doi: 10.1016/j.radonc.2017.11.024.
   PubMed Web of Science ®Google Scholar